Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1900578 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Huiye Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, University of Maryland, College Park, MD, United States. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Parkinson's disease (PD) is increasingly recognized as a multisystem disorder in which gastrointestinal dysfunction and gut microbial alterations may contribute to disease pathophysiology. Although most microbiome research in PD has focused on bacteria, growing evidence suggests that the gut ecosystem should be considered more broadly to include fungi, viruses, metabolites, and proteins.
Methods
We searched PubMed and SciFinder for human studies published up to October 28, 2025, using domain-specific search strategies for the bacteriome, metabolome, proteome, virome, and mycobiome, and synthesized the eligible evidence using a structured multi-omics evidence-mapping framework.
Results
We summarize the most consistent bacterial findings, including enrichment of mucin-degrading taxa and depletion of short-chain fatty acid-producing commensals, and discuss how these changes relate to impaired fermentation, barrier dysfunction, and immune activation. We further examine emerging evidence for virome and mycobiome alterations, highlighting the possibility that PD-related dysbiosis reflects cross-kingdom ecological disruption rather than bacteria-only imbalance. Metabolomic studies provide functional support for this model by demonstrating altered short-chain fatty acid biology and broader host -microbe co-metabolic remodeling. Protein-focused studies, including host proteomic signatures and bacterial functional amyloids, extend the field toward mechanisms linking gut dysfunction to inflammation, proteostatic stress, and α-synuclein pathology.
Discussion
Overall, the evidence supports a multi-layer view of the PD gut -brain axis in which microbial ecology, metabolic output, barrier integrity, immune signaling, and protein-centered mechanisms are interconnected. The field remains limited by cross-sectional designs, methodological heterogeneity, and uneven evidence depth across omics layers. Longitudinal, standardized, and integrated multi-omics studies will be essential to determine which microbiome-associated alterations are mechanistically important, clinically informative, and potentially modifiable in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mathematics, University of Maryland, College Park, MD, United States.
- Winston Churchill High School, Potomac, MD, United States.
- Department of Epidemiology and Biostatistics, University of Maryland, College Park, MD, United States.
- Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
Zitieren
APA
Han, H., Luo, O., Li, K., Rahaman, S., Ok, E. U., Zhang, L., Liang, M., & Lin, H. (2026). Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1900578
Vancouver
Han H, Luo O, Li K, Rahaman S, Ok EU, Zhang L, et al. Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1900578
BibTeX
@article{Han2026,
author = {Han, Huiye and Luo, Owen and Li, Kevin and Rahaman, Shyazana and Ok, Eunice Unbyul and Zhang, Liangliang and Liang, Menglu and Lin, Huang},
title = {Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1900578}
}
EUVIMED